Squeeze Report — July 24, 2026
Biotech dominates today's book, but the real tension is between extreme positioning and fragile fundamentals. The highest-conviction names—CADL, GRPN, IBRX—pair triple-digit short interest or massive rallies with dilution overhangs and going-concern warnings, making the next earnings catalyst a binary event.
Today's top short-squeeze candidates
- #1CERTCertara, Inc. Common Stock78
A 31% rally into Q2 earnings pressures a 27% short interest, but a CFO exit and law-firm investigations justify the bear case.
SI 27%DTC 5.0$7.11+31% 20dHealthcare - #2NTSTNetSTREIT Corp.78
37% of float sold short · 7.2 days to cover · +7% over 20 days
SI 37%DTC 7.2$21.83+7% 20dReal Estate - #3IMVTImmunovant, Inc. Common Stock77
23% of float sold short · 8.6 days to cover · +3% over 20 days
SI 23%DTC 8.6$39.37+3% 20dHealthcare - #4UPWKUpwork Inc. Common Stock77
22% of float sold short · 6.9 days to cover · +6% over 20 days
SI 22%DTC 6.9$8.72+6% 20dIndustrials - #5REPLReplimune Group, Inc. Common S76
31% of float sold short · 6.4 days to cover · -7% over 20 days
SI 31%DTC 6.4$10.46-7% 20dHealthcare - #6GRPNGroupon, Inc. Common Stock76
A 60% short interest against a 39% 20-day surge and aggressive buyback is a pressure cooker, but the underlying business is deeply unprofitable.
SI 60%DTC 6.1$25.42+39% 20dCommunication Services - #7AESIAtlas Energy Solutions Inc.75
25% of float sold short · 7.3 days to cover · -17% over 20 days
SI 25%DTC 7.3$13.07-17% 20dEnergy - #8IOVAIovance Biotherapeutics, Inc.75
34% of float sold short · 7.1 days to cover · +21% over 20 days
SI 34%DTC 7.1$5.13+21% 20dHealthcare - #9TRIPTripAdvisor, Inc. Common Stock75
29% of float sold short · 8.3 days to cover · +4% over 20 days
SI 29%DTC 8.3$13.49+4% 20dConsumer Cyclical - #10HRBH&R Block, Inc.75
15% of float sold short · 8.8 days to cover · +10% over 20 days
SI 15%DTC 8.8$39.95+10% 20dConsumer Cyclical - #11PGENPrecigen, Inc. Common Stock75
Newly approved Papzimeos is beating revenue estimates, but negligible borrow fees mean shorts feel no pain without a Q2 beat-and-raise.
SI 36%DTC 7.6$5.54+3% 20dHealthcare - #12IBRXImmunityBio, Inc. Common Stock75
Short interest at 116% of float and a tight borrow could ignite on warrant expiries, but a going-concern warning makes this a bankruptcy-or-moonshot trade.
SI 116%DTC 8.7$7.40-5% 20dHealthcare - #13SGMTSagimet Biosciences Inc. Serie75
A 42% surge in short interest is likely overstated after a $175M offering nearly doubled the float, weakening the squeeze math.
SI 26%DTC 3.9$7.01+1% 20dHealthcare - #14AGENAgenus Inc. Common Stock74
16% of float sold short · 5.4 days to cover · +112% over 20 days
SI 16%DTC 5.4$6.19+112% 20dHealthcare - #15CADLCandel Therapeutics, Inc. Comm74
A 34% short interest and call-heavy options chain set the stage for a gamma squeeze into Aug OPEX, though a $300M shelf overhang lurks.
SI 34%DTC 6.0$9.86+6% 20dHealthcare
See the full ranked board
This is the top sliver of 15 names we rank every day. The live board carries rank history, days-to-cover fuel gauges, AI research, and a backtested signal validator.
Open the live squeeze board →